Literature DB >> 14925143

Triethylene melamine in the treatment of neoplastic disease.

R W RUNDLES, W B BARTON.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE/therapy; LEUKEMIA, LYMPHATIC/therapy; TRIETHYLENE MELAMINE/therapeutic use

Mesh:

Substances:

Year:  1952        PMID: 14925143

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  TRYPSIN in thrombo-embolic disease.

Authors: 
Journal:  Br Med J       Date:  1955-06-04

2.  Chemotherapy of cancer.

Authors:  K A NEWTON
Journal:  Postgrad Med J       Date:  1958-12       Impact factor: 2.401

3.  Malignant lymphoma. A report of two contrasting cases in children.

Authors:  L L ALEXANDER
Journal:  J Natl Med Assoc       Date:  1960-07       Impact factor: 1.798

4.  [Blood protein picture in leukemias and in diseases of the lymphatic system].

Authors:  W REMMELE
Journal:  Blut       Date:  1957-05

5.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

6.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

7.  The chemical control of cancer.

Authors:  J F HOLLAND
Journal:  Public Health Rep       Date:  1954-12       Impact factor: 2.792

8.  The present status of radiotherapy and chemotherapy in the treatment of chronic leukaemia; a review.

Authors:  M HULBERT
Journal:  Postgrad Med J       Date:  1954-02       Impact factor: 2.401

9.  Chemical agents in neoplastic diseases; an evaluation of chemotherapeutic substances for clinical management.

Authors:  H R BIERMAN
Journal:  Calif Med       Date:  1953-01

10.  [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].

Authors:  H MARTIN
Journal:  Klin Wochenschr       Date:  1953-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.